ConductScience.org, home

Paper6533296

Ocular and systemic bioavailability of ophthalmic flurbiprofen.

Tang-Liu DD and 2 others. J Pharmacokinet Biopharm, 1984. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Ocular and systemic bioavailability of ophthalmic flurbiprofen. Papers, record 6533296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6533296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ocular and systemic bioavailability of ophthalmic flurbiprofen.
PubMed
Journal
J Pharmacokinet Biopharm
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
3.3
iCite
Revised in PubMed
2019-10-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tang-Liu DDD D
2Liu SSS S
3Weinkam RJR J

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EyeMajor topic
FlurbiprofenMajor topic
PropionatesMajor topic
Administration, Topical
Animals
Aqueous Humor
Biological Availability
Chromatography, Liquid
Eye Proteins
Female
Injections, Intravenous
Ophthalmic Solutions
Rabbits

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120491Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine.J Pharm Sci1977https://conductscience.org/library/papers/20491PubMed
25548248Drug-absorption analysis from pharmacological data. I. Method and confirmation exemplified for the mydriatic drug tropicamide.J Pharm Sci1971https://conductscience.org/library/papers/5548248PubMed
31133744Vehicle effects on ocular drug bioavailability i: evaluation of fluorometholone.J Pharm Sci1975https://conductscience.org/library/papers/1133744PubMed
47229908Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.J Pharmacokinet Biopharm1980https://conductscience.org/library/papers/7229908PubMed
5641790Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye.J Pharm Sci1978https://conductscience.org/library/papers/641790PubMed
67073585Disposition of topical flurbiprofen in normal and aphakic rabbit eyes.Arch Ophthalmol1982https://conductscience.org/library/papers/7073585PubMed
74752109Altered bioavailability of drugs in the eye due to drug-protein interaction.J Pharm Sci1973https://conductscience.org/library/papers/4752109PubMed
8623195Ocular bioavailability and systemic loss of topically applied ophthalmic drugs.Am J Ophthalmol1978https://conductscience.org/library/papers/623195PubMed
9839419Aqueous chamber drug distribution volume measurement in rabbits.J Pharm Sci1977https://conductscience.org/library/papers/839419PubMed
104621283Permeability of the cornea to topically applied drugs.Arch Ophthalmol1974https://conductscience.org/library/papers/4621283PubMed
114823783Corneal permeation of topical pilocarpine nitrate in the rabbit.Am J Ophthalmol1974https://conductscience.org/library/papers/4823783PubMed
12194383Prostaglandins, nonsteroidal anti-inflammatory agents and eye disease.Trans Am Ophthalmol Soc1976https://conductscience.org/library/papers/194383PubMed
13977253Comparison of ocular prostaglandin synthesis inhibitors.Invest Ophthalmol1976https://conductscience.org/library/papers/977253PubMed
144712631Biophasic availability of ophthalmic carbachol. I. Mechanisms of cationic polymer- and surfactant-promoted miotic activity.J Pharm Sci1973https://conductscience.org/library/papers/4712631PubMed
15848546Penetration of topically administered prednisolone acetate into the human aqueous humor.Am J Ophthalmol1977https://conductscience.org/library/papers/848546PubMed
164829994Corneal absorption of ophthalmic drugs.J Pharm Sci1974https://conductscience.org/library/papers/4829994PubMed
17480170Noncompartmental determination of the steady-state volume of distribution.J Pharm Sci1979https://conductscience.org/library/papers/480170PubMed
187041308Pharmacokinetics of topically applied ophthalmic drugs.Surv Ophthalmol1982https://conductscience.org/library/papers/7041308PubMed

Download CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
37376094Corneal Permeability and Uptake of Twenty-Five Drugs: Species Comparison and Quantitative Structure-Permeability Relationships.Pharmaceutics2023https://conductscience.org/library/papers/37376094PubMed
29988879A Case of Allergic Urticaria After Ophthalmic Nepafenac Use.Turk J Ophthalmol2018https://conductscience.org/library/papers/29988879PubMed
28736344TFOS DEWS II Clinical Trial Design Report.Ocul Surf2017https://conductscience.org/library/papers/28736344PubMed
18792792Effect of pH and formulation variables on in vitro transcorneal permeability of flurbiprofen: a technical note.AAPS PharmSciTech2008https://conductscience.org/library/papers/18792792PubMed
18437583Topical ocular delivery of NSAIDs.AAPS J2008https://conductscience.org/library/papers/18437583PubMed
18219479Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops.Eur J Clin Pharmacol2008https://conductscience.org/library/papers/18219479PubMed
11994027Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.Drug Saf2002https://conductscience.org/library/papers/11994027PubMed
10380237Flurbiprofen, S(+), eyedrops: formulation, enantiomeric assay, shelf-life and pharmacology.Pharm World Sci1999https://conductscience.org/library/papers/10380237PubMed
3746638Ocular pharmacokinetic models of clonidine-3H hydrochloride.J Pharmacokinet Biopharm1986https://conductscience.org/library/papers/3746638PubMed
3681666Relationship between the ocular and systemic disposition of flurbiprofen: the effect of altered protein dynamics at steady state.J Pharmacokinet Biopharm1987https://conductscience.org/library/papers/3681666PubMed
3073384The effect of azone on ocular levobunolol absorption: calculating the area under the curve and its standard error using tissue sampling compartments.Pharm Res1988https://conductscience.org/library/papers/3073384PubMed
2182264Ocular drug delivery. Pharmacokinetic considerations.Clin Pharmacokinet1990https://conductscience.org/library/papers/2182264PubMed
1479559Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye.J Pharmacokinet Biopharm1992https://conductscience.org/library/papers/1479559PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6533296

GET https://conductscience.org/api/papers/v1/6533296/authors